[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352636-105":59,"doc-detail-352636-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gene-expression-profile-gep-comparison-of-atypical-fibroxanthoma-afx-and-pleomorphic-dermal-sarcoma-pds","Gene Expression Profile (GEP) Comparison of Atypical Fibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS)","","Gene-expression profiling is used to compare atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS), related dermal tumors that form opposite ends of a clinical and histopathologic spectrum. RNA sequencing on a small AFX/PDS series applies a Pan-Cancer RNA Panel and is analyzed by unsupervised clustering. Although both groups share a TP53 UV-radiation signature and overlapping DNA mutation profiles, RNA sequencing identifies distinct transcriptomic signatures. MAPK pathway, DNA repair, EMT-like and inflammatory response programs, plus differences in receptor tyrosine kinase expression, support molecular distinction and may guide improved classification and future therapy targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gene-expression-profile-gep-comparison-of-atypical-fibroxanthoma-afx-and-pleomorphic-dermal-sarcoma-pds/352636/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gene-expression-profile-gep-comparison-of-atypical-fibroxanthoma-afx-and-pleomorphic-dermal-sarcoma-pds/352636.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does AFX relate to PDS clinically and histopathologically?","Question",{"text":112,"@type":113},"AFX and PDS lie on a shared clinical and histopathologic spectrum, with AFX typically low-grade and PDS representing the more aggressive counterpart.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What method was used to generate the gene-expression profiles?",{"text":117,"@type":113},"RNA sequencing using a Pan-Cancer RNA Panel was performed on a small series of AFX and PDS samples.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings when comparing RNA and DNA profiles?",{"text":121,"@type":113},"Unsupervised clustering separated the two groups, and a TP53 UV-radiation signature was confirmed in both. Despite overlapping DNA mutation profiles in the cohort, RNA sequencing revealed distinct gene-expression signatures, including MAPK pathway, DNA repair, EMT-like, and inflammatory response programs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352636,1791390535,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nGene Expression Profile (GEP) Comparison of Atypical  \nFibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS)  \nAlessio Giubellino 1,2, *, Gerardo Cazzato 3, Mario Della Mura 3, Giuseppe Broggi 4, Alessandro Rizzo 5, Nehaaluddin Azmi 1, Carlos A. Torres-Cabala 6, Sarah Munro 7 and Faqian Li 8  \nAcademic Editor: Karen E. Pollok  \nReceived: 10 January 2026  \nRevised: 10 March 2026  \nAccepted: 11 March 2026  \nPublished: 13 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA  \n2 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA  \n3 Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, 70121 Bari, Italy  \n4 Department of Medical and Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, Anatomic Pathology, University of Catania, 95131 Catania, Italy; [giuseppe.broggi@gmail.com](giuseppe.broggi@gmail.com)  \n5 IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy  \n6 Department of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA  \n7 Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USA  \n8 Department of Pathology and Laboratory Medicine, University of Texas San Antonio, San Antonio, TX 78249, USA  \n* Correspondence: [agiubell@umn.edu](agiubell@umn.edu)  \nSimple Summary  \nAtypical fibroxanthoma (AFX) is a low-grade tumor related to the more aggressive cutaneous undifferentiated pleomorphic sarcoma (cUPS)/pleomorphic dermal sarcoma (PDS) . While they both share a common DNA profile, we explore their RNA expression profile and show that it is different, including specific MAPK pathway, DNA repair and inflammatory response profiles, at least in our cohort. This different gene expression profile can be potentially leveraged to improve correct classification and potentially to define future potential targets for therapy.  \nAbstract  \nBackground/Objectives: Atypical fibroxanthoma (AFX) and cutaneous undifferentiated pleomorphic sarcoma (cUPS)/pleomorphic dermal sarcoma (PDS) are related dermal neoplasms of uncertain histogenesis that occupy opposite ends of a shared clinical and histopathologic spectrum, with AFX displaying typically low-grade behavior and PDS representing its more aggressive counterpart. The recent literature has confirmed that AFX and PDS also overlap at the molecular and genomic levels; however, little is known about their gene-expression profiles. Methods: We performed gene-expression profiling using RNA sequencing with a Pan-Cancer RNA Panel on a small series of AFX and PDS samples. Results: Unsupervised cluster analysis showed a clear separation between the two groups. We confirmed a TP53 UV-radiation signature in both. However, while AFX and PDS share common DNA mutation profiles in our cohort, RNA sequencing reveals distinct gene-expression signatures that may aid in differentiating these related tumors. In particular, the MAPK pathway, cell adhesion, DNA repair, EMT-like signaturesand inflammatory responses play key roles in distinguishing the two groups, at least in our limited cohort, consistent with their differing biological behavior. Differences in the expression of receptor tyrosine kinases were also observed. Conclusions: Gene-expression profiling have the potential to be a valuable tool for distinguishing AFX from PDS, clarifying their positions at opposite ends of a spectrum and providing deeper insight into the biology of these neoplasms.  \nKeywords: atypical fibroxanthoma; pleomorphic dermal sarcoma; cutaneous undifferentiated pleomorphic sarcoma; RNA; transcriptome  \n1. Introduction  \nAtypical fibroxanthoma (AFX) a","cbCaiioajFE5HPl3","https://ap.wps.com/l/cbCaiioajFE5HPl3","pdf",2941691,13,"English","# Simple Summary\n# Abstract\n# 1. Introduction","[{\"question\":\"How does AFX relate to PDS clinically and histopathologically?\",\"answer\":\"AFX and PDS lie on a shared clinical and histopathologic spectrum, with AFX typically low-grade and PDS representing the more aggressive counterpart.\"},{\"question\":\"What method was used to generate the gene-expression profiles?\",\"answer\":\"RNA sequencing using a Pan-Cancer RNA Panel was performed on a small series of AFX and PDS samples.\"},{\"question\":\"What were the key findings when comparing RNA and DNA profiles?\",\"answer\":\"Unsupervised clustering separated the two groups, and a TP53 UV-radiation signature was confirmed in both. Despite overlapping DNA mutation profiles in the cohort, RNA sequencing revealed distinct gene-expression signatures, including MAPK pathway, DNA repair, EMT-like, and inflammatory response programs.\"}]","Gene Expression Profile (GEP) Comparison of Atypical Fibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS) | PDF",1790100565,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fee8e434ac4f9b063a056d7b09d1800e.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5aa0757073106681c373efb2d50eebec.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac64746ed81aba31b8127245b8366ed3.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b16bf1d9d35b36944d664c4b75f8d9ec.webp",980,692]